Vabrinty

Product NDC: 85043-025
11-digit product format: 850430025
Labeler code: 85043
Product ID: 85043-025_b8da8614-75a8-453c-be31-0568da16a3b9
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Leuprolide acetate
Dosage form: INJECTION, SUSPENSION, EXTENDED RELEASE
Route: SUBCUTANEOUS
Labeler: URONOVA PHARMACEUTICALS, INC.
Application: NDA021379
Marketing category: NDA AUTHORIZED GENERIC
Marketing start: 2025-08-04
Substance: LEUPROLIDE ACETATE
Active strength: 22.5 mg/.375mL
Pharmacologic classes: Gonadotropin Releasing Hormone Receptor Agonist [EPC], Gonadotropin Releasing Hormone Receptor Agonists [MoA]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N021379-001	ELIGARD KIT	LEUPROLIDE ACETATE	22.5MG	POWDER / SUBCUTANEOUS		RLD, RS	2002-07-24

Orange Book patents#

Current patent rows page 1 of 1 · 3 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N021379-001	11771841	2041-12-22		Drug substance, Drug product	2023-10-27
N021379-001	11931559	2041-12-22		Drug substance	2024-04-15
N021379-001	12397120	2041-12-22	U-4001		2025-09-22

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N021379-001	ELIGARD KIT	22.5MG	POWDER / SUBCUTANEOUS	RLD, RS	2002-07-24	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021379-001	ELIGARD KIT	22.5MG	POWDER / SUBCUTANEOUS	RLD, RS	2002-07-24	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021379-001	ELIGARD KIT	22.5MG	POWDER / SUBCUTANEOUS	RLD, RS	2002-07-24	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021379-001	ELIGARD KIT	22.5MG	POWDER / SUBCUTANEOUS	RLD, RS	2002-07-24	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021379-001	ELIGARD KIT	22.5MG	POWDER / SUBCUTANEOUS	RLD, RS	2002-07-24	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021379-001	ELIGARD KIT	22.5MG	POWDER / SUBCUTANEOUS	RLD, RS	2002-07-24	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021379-001	ELIGARD KIT	22.5MG	POWDER / SUBCUTANEOUS	RLD, RS	2002-07-24	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021379-001	ELIGARD KIT	22.5MG	POWDER / SUBCUTANEOUS	RLD, RS	2002-07-24	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021379-001	ELIGARD KIT	22.5MG	POWDER / SUBCUTANEOUS	RLD, RS	2002-07-24	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021379-001	ELIGARD KIT	22.5MG	POWDER / SUBCUTANEOUS	RLD, RS	2002-07-24	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021379-001	ELIGARD KIT	22.5MG	POWDER / SUBCUTANEOUS	RLD, RS	2002-07-24	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021379-001	ELIGARD KIT	22.5MG	POWDER / SUBCUTANEOUS	RLD, RS	2002-07-24	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021379-001	ELIGARD KIT	22.5MG	POWDER / SUBCUTANEOUS	RLD, RS	2002-07-24	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N021379-001	ELIGARD KIT	22.5MG	POWDER / SUBCUTANEOUS	RLD, RS	2002-07-24	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021379-001	ELIGARD KIT	22.5MG	POWDER / SUBCUTANEOUS	RLD, RS	2002-07-24	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N021379-001	ELIGARD KIT	22.5MG	POWDER / SUBCUTANEOUS	RLD, RS	2002-07-24	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N021379-001	ELIGARD KIT	22.5MG	POWDER / SUBCUTANEOUS	RLD, RS	2002-07-24	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N021379-001	ELIGARD	22.5MG/VIAL	INJECTABLE / SUBCUTANEOUS	RLD, RS	2002-07-24	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N021379-001	ELIGARD KIT	22.5MG	POWDER / SUBCUTANEOUS	RLD, RS	2002-07-24	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N021379-001	ELIGARD KIT	22.5MG	POWDER / SUBCUTANEOUS	RLD, RS	2002-07-24	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021379-001	ELIGARD KIT	22.5MG	POWDER / SUBCUTANEOUS	RLD, RS	2002-07-24	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N021379-001	ELIGARD KIT	22.5MG	POWDER / SUBCUTANEOUS	RLD, RS	2002-07-24	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N021379-001	ELIGARD KIT	22.5MG	POWDER / SUBCUTANEOUS	RLD, RS	2002-07-24	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N021379-001	ELIGARD KIT	22.5MG	POWDER / SUBCUTANEOUS	RLD, RS	2002-07-24	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N021379-001	ELIGARD	22.5MG/VIAL	INJECTABLE / SUBCUTANEOUS	RLD, RS	2002-07-24	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N021379-001	ELIGARD	22.5MG/VIAL	INJECTABLE / SUBCUTANEOUS	RLD, RS	2002-07-24	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N021379-001	ELIGARD	22.5MG/VIAL	INJECTABLE / SUBCUTANEOUS	RLD, RS	2002-07-24	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N021379-001	ELIGARD KIT	22.5MG	POWDER / SUBCUTANEOUS	RLD, RS	2002-07-24	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N021379-001	ELIGARD KIT	22.5MG	POWDER / SUBCUTANEOUS	RLD, RS	2002-07-24	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N021379-001	ELIGARD KIT	22.5MG	POWDER / SUBCUTANEOUS	RLD, RS	2002-07-24	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N021379-001	ELIGARD KIT	22.5MG	POWDER / SUBCUTANEOUS	RLD, RS	2002-07-24	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N021379-001	ELIGARD KIT	22.5MG	POWDER / SUBCUTANEOUS	RLD, RS	2002-07-24	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N021379-001	ELIGARD KIT	22.5MG	POWDER / SUBCUTANEOUS	RLD, RS	2002-07-24	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N021379-001	ELIGARD KIT	22.5MG	POWDER / SUBCUTANEOUS	RLD, RS	2002-07-24	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N021379-001	ELIGARD KIT	22.5MG	POWDER / SUBCUTANEOUS	RLD, RS	2002-07-24	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N021379-001	ELIGARD KIT	22.5MG	POWDER / SUBCUTANEOUS	RLD, RS	2002-07-24	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N021379-001	ELIGARD KIT	22.5MG	POWDER / SUBCUTANEOUS	RLD, RS	2002-07-24	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N021379-001	ELIGARD KIT	22.5MG	POWDER / SUBCUTANEOUS	RLD, RS	2002-07-24	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N021379-001	ELIGARD KIT	22.5MG	POWDER / SUBCUTANEOUS	RLD, RS	2002-07-24	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N021379-001	ELIGARD KIT	22.5MG	POWDER / SUBCUTANEOUS	RLD, RS	2002-07-24	`cb3db0bc1861…`

Observed Orange Book patent history#

Patent history page 1 of 2 · 79 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N021379-001	11771841	2041-12-22		Drug substance, Drug product	2023-10-27	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021379-001	11931559	2041-12-22		Drug substance	2024-04-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021379-001	12397120	2041-12-22	U-4001		2025-09-22	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021379-001	11771841	2041-12-22		Drug substance, Drug product	2023-10-27	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021379-001	11931559	2041-12-22		Drug substance	2024-04-15	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021379-001	12397120	2041-12-22	U-4001		2025-09-22	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021379-001	11771841	2041-12-22		Drug substance, Drug product	2023-10-27	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021379-001	11931559	2041-12-22		Drug substance	2024-04-15	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021379-001	11771841	2041-12-22		Drug substance, Drug product	2023-10-27	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021379-001	11931559	2041-12-22		Drug substance	2024-04-15	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021379-001	11771841	2041-12-22		Drug substance, Drug product	2023-10-27	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021379-001	11931559	2041-12-22		Drug substance	2024-04-15	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021379-001	11771841	2041-12-22		Drug substance, Drug product	2023-10-27	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021379-001	11931559	2041-12-22		Drug substance	2024-04-15	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021379-001	11771841	2041-12-22		Drug substance, Drug product	2023-10-27	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021379-001	11931559	2041-12-22		Drug substance	2024-04-15	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021379-001	11771841	2041-12-22		Drug substance, Drug product	2023-10-27	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021379-001	11931559	2041-12-22		Drug substance	2024-04-15	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021379-001	11771841	2041-12-22		Drug substance, Drug product	2023-10-27	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021379-001	11931559	2041-12-22		Drug substance	2024-04-15	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021379-001	11771841	2041-12-22		Drug substance, Drug product	2023-10-27	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021379-001	11931559	2041-12-22		Drug substance	2024-04-15	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021379-001	11771841	2041-12-22		Drug substance, Drug product	2023-10-27	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021379-001	11931559	2041-12-22		Drug substance	2024-04-15	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021379-001	11771841	2041-12-22		Drug substance, Drug product	2023-10-27	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021379-001	11931559	2041-12-22		Drug substance	2024-04-15	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021379-001	11771841	2041-12-22		Drug substance, Drug product	2023-10-27	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021379-001	11931559	2041-12-22		Drug substance	2024-04-15	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N021379-001	11771841	2041-12-22		Drug substance, Drug product	2023-10-27	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N021379-001	11931559	2041-12-22		Drug substance	2024-04-15	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021379-001	8470359	2023-10-15	U-621	Drug substance, Drug product	2017-01-31	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N021379-001	8470359	2023-10-15	U-621	Drug substance, Drug product	2017-01-31	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N021379-001	8470359	2023-10-15	U-621	Drug substance, Drug product	2017-01-31	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N021379-001	6626870	2020-03-27		Drug product		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021379-001	8840916	2020-11-13		Drug product	2017-01-31	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021379-001	9539333	2020-11-13	U-621	Drug substance, Drug product	2017-01-31	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021379-001	8470359	2023-10-15	U-621	Drug substance, Drug product	2017-01-31	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N021379-001	8470359	2023-10-15	U-621	Drug substance, Drug product	2017-01-31	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N021379-001	8470359	2023-10-15	U-621	Drug substance, Drug product	2017-01-31	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021379-001	8470359	2023-10-15	U-621	Drug substance, Drug product	2017-01-31	`87673890dc5c…`

Additional Listing Data#

Finished product: Yes
Brand name base: Vabrinty
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
LEUPROLIDE ACETATE	22.5 mg/.375mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
37JNS02E7V	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 8 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
752889	Internal RxNorm lookup
752894	Internal RxNorm lookup
752899	Internal RxNorm lookup
2720345	Internal RxNorm lookup
2720348	Internal RxNorm lookup
2723399	Internal RxNorm lookup
2728996	Internal RxNorm lookup
752884	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
008776cc-83f1-4f8c-819b-6471425da15f	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
9e666f57-491f-16e0-fc75-cc1c9f2fe06f	Product name	4	20250515
43944b95-6cc2-4eca-846a-a5e0ed070616	Product name	1	20240501
f3ff4518-37fe-47a0-8a1e-6ce032a3efd5	Product name	1	20230829
2ed2d111-4d16-4e2a-9b09-7d196056f6c9	Product name	1	20211214
ce98e98f-fa6b-48a6-8ad2-9ef8e8098f26	Product name	1	20200925
23ede539-308f-46e5-817b-41ef23af8d40	Product name	1	20150930
425e3610-bbe8-4d70-9c46-8cf09afc4e4d	Product name	1	20150930
ae18ed71-8057-40ec-987f-83624e50b906	Product name	1	20150122

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
85043-025-02	Vabrinty	1 in 1 CARTON	INJECTION, SUSPENSION, EXTENDED	1		9
85043-025-02	Vabrinty	0.375 mL in 1 SYRINGE	INJECTION, SUSPENSION, EXTENDED	0.375		9

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
85043-025-02	EA - Each	85043-025	15c7aff2-90aa-4319-8e41-55dcb16a9fe2	1	2025-09-12

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Vabrinty	LEUPROLIDE ACETATE	URONOVA PHARMACEUTICALS, INC.	008776cc-83f1-4f8c-819b-6471425da15f	2026-04-30	Warnings, Adverse reactions	Exact identifier application applno (NDA): 021379 application number: NDA021379 ndc (product): 85043-025
Eligard	LEUPROLIDE ACETATE	TOLMAR Inc.	b7b679a9-6823-4ef8-8d31-3ab5058ffcfc	2026-04-30	Warnings, Adverse reactions	Exact identifier application applno (NDA): 021379 application number: NDA021379
ELIGARD	LEUPROLIDE ACETATE	TOLMAR Inc.	b78d1919-9dee-44fa-90f9-e0a26d32481d	2019-04-29	Warnings, Adverse reactions	Exact identifier application applno (NDA): 021379 application number: NDA021379

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
37JNS02E7V	LEUPROLIDE ACETATE	74381-53-6	LEUPROLIDE ACETATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
752894	leuprolide acetate 22.5 MG in 0.375 mL (3 month) Prefilled Syringe	PSN	008776cc-83f1-4f8c-819b-6471425da15f	9
752889	leuprolide acetate 30 MG in 0.5 ML (4 month) Prefilled Syringe	PSN	008776cc-83f1-4f8c-819b-6471425da15f	9
752884	leuprolide acetate 45 MG in 0.375 ML (6 month) Prefilled Syringe	PSN	008776cc-83f1-4f8c-819b-6471425da15f	9
752899	leuprolide acetate 7.5 MG in 0.25 ML (1 month) Prefilled Syringe	PSN	008776cc-83f1-4f8c-819b-6471425da15f	9
2720345	Vabrinty 22.5 MG in 0.375 ML (3 month) Prefilled Syringe	PSN	008776cc-83f1-4f8c-819b-6471425da15f	9
2723399	Vabrinty 30 MG in 0.5 ML (4 month) Prefilled Syringe	PSN	008776cc-83f1-4f8c-819b-6471425da15f	9
2720348	Vabrinty 45 MG in 0.375 ML (6 month) Prefilled Syringe	PSN	008776cc-83f1-4f8c-819b-6471425da15f	9
2728996	Vabrinty 7.5 MG in 0.25 ML (1 month) Prefilled Syringe	PSN	008776cc-83f1-4f8c-819b-6471425da15f	9
2728996	0.25 ML leuprolide acetate 30 MG/ML Prefilled Syringe [Vabrinty]	SBD	008776cc-83f1-4f8c-819b-6471425da15f	9
2720348	0.375 ML leuprolide acetate 120 MG/ML Prefilled Syringe [Vabrinty]	SBD	008776cc-83f1-4f8c-819b-6471425da15f	9
2720345	0.375 ML leuprolide acetate 60 MG/ML Prefilled Syringe [Vabrinty]	SBD	008776cc-83f1-4f8c-819b-6471425da15f	9
2723399	0.5 ML leuprolide acetate 60 MG/ML Prefilled Syringe [Vabrinty]	SBD	008776cc-83f1-4f8c-819b-6471425da15f	9
752899	0.25 ML leuprolide acetate 30 MG/ML Prefilled Syringe	SCD	008776cc-83f1-4f8c-819b-6471425da15f	9
752884	0.375 ML leuprolide acetate 120 MG/ML Prefilled Syringe	SCD	008776cc-83f1-4f8c-819b-6471425da15f	9
752894	0.375 ML leuprolide acetate 60 MG/ML Prefilled Syringe	SCD	008776cc-83f1-4f8c-819b-6471425da15f	9
752889	0.5 ML leuprolide acetate 60 MG/ML Prefilled Syringe	SCD	008776cc-83f1-4f8c-819b-6471425da15f	9
2728996	0.25 ML Vabrinty 30 MG/ML Prefilled Syringe	SY	008776cc-83f1-4f8c-819b-6471425da15f	9
752894	leuprolide acetate 22.5 MG per 0.375 ML (3 month) Prefilled Syringe	SY	008776cc-83f1-4f8c-819b-6471425da15f	9
752894	leuprolide acetate 22.5 MG per 0.375 ML Prefilled Syringe	SY	008776cc-83f1-4f8c-819b-6471425da15f	9
752889	leuprolide acetate 30 MG per 0.5 ML (4 month) Prefilled Syringe	SY	008776cc-83f1-4f8c-819b-6471425da15f	9
752884	leuprolide acetate 45 MG per 0.375 ML (6 month) Prefilled Syringe	SY	008776cc-83f1-4f8c-819b-6471425da15f	9
752884	leuprolide acetate 45 MG per 0.375 ML Prefilled Syringe	SY	008776cc-83f1-4f8c-819b-6471425da15f	9
752899	leuprolide acetate 7.5 MG per 0.25 ML Prefilled Syringe	SY	008776cc-83f1-4f8c-819b-6471425da15f	9
2720345	Vabrinty 22.5 MG per 0.375 ML Prefilled Syringe	SY	008776cc-83f1-4f8c-819b-6471425da15f	9
2723399	Vabrinty 30 MG per 0.5 ML Prefilled Syringe	SY	008776cc-83f1-4f8c-819b-6471425da15f	9
2720348	Vabrinty 45 MG per 0.375 ML Prefilled Syringe	SY	008776cc-83f1-4f8c-819b-6471425da15f	9
2728996	Vabrinty 7.5 MG per 0.25 ML Prefilled Syringe	SY	008776cc-83f1-4f8c-819b-6471425da15f	9

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Sample	Exclude flag	Status
85043-025-02	85043002502	1 SYRINGE in 1 CARTON (85043-025-02) / .375 mL in 1 SYRINGE	1 syringe	2025-08-04	No	No	Current